New Vaginal Gel Reduces HIV Infection Rates by 54%

hiv_vaginal_gel

The HIV reducing microbe.

A trial of a powerful new microbicidal vaginal gel reduced the HIV infection rate of test subjects by 54%. The gel is a 1% solution of the antiretroviral drug tenofovir, which stops HIV replication. At Scientific American, Katherine Harmon writes:

A reliable HIV-prevention method for women has thus far proved hard to come by, leaving many millions of at-risk women subject to their partner’s decision about condoms…

 

Continue reading… “New Vaginal Gel Reduces HIV Infection Rates by 54%”

0